Abstract:Background: Although positive airway pressure (PAP) therapy is considered first-line treatment for obstructive sleep apnea (OSA), non-adherence is common. Numerous factors influence PAP use, including a belief that the therapy is important and effective. In theory, providing information to patients about their blood oxygen levels during sleep, which may be low when PAP is not used, juxtaposed to information about their PAP use may influence a patient's beliefs about therapy and increase PAP use. With the advent of consumer wearable smartwatches' blood oxygen saturation monitoring capability (and the existing routine availability of PAP use data transmitted via modem to clinical dashboards), there is an opportunity to provide this combination of information to patients. Objective: The Chronic care management with wearable devices in patients prescribed Positive Airway Pressure therapy (mPAP) study is a pilot randomized waitlist-controlled trial testing the feasibility, acceptability, and preliminary efficacy of a program that augments current PAP therapy data with consumer-grade wearable device to promote self-management of PAP therapy for OSA. Methods: Single-blinded randomized controlled trial. We will randomize 50 individuals with a history of OSA who receive care from a Department of Veterans Affairs medical center in the Los Angeles area and are nonadherent to prescribed PAP therapy to Immediate intervention or Waitlist control. During a 28-day intervention, the participants will wear a study-provided consumer wearable device and complete a weekly survey about their OSA symptoms. A report that summarizes consumer wearable-provided oxygen saturation values, PAP use derived from modem data, and patient-reported OSA symptoms will be prepared weekly and shared with the patient. Immediate intervention group will begin intervention immediately after randomization (T1). Assessments will occur at week 5 (T3; one-week post-treatment for Immediate intervention group and repeat baseline for Waitlist control group) and week 11 (T5; follow-up for Immediate intervention group and one-week post-treatment for Waitlist control group). The primary outcome will be the change in 7-day PAP adherence (average minutes/night) from T1 to T3. The primary analysis will be a comparison of the primary outcome between the Immediate intervention and the Waitlist control groups (intention-to-treat design), using a two-sample t-test on change scores (unadjusted). Results: Recruitment began in October 2023. Data analysis is expected to begin in October 2024 when all follow-ups are complete, and a manuscript summarizing trial results will be submitted following completion of data analysis. Conclusions: Findings from the study may provide additional insights on how patients with OSA might use patient-generated health data collected by consumer wearables to inform self-management of OSA, and possibly increase their use of PAP therapy. Clinicaltrial: ClinicalTrials.gov NCT06039865.

0543 The Utility of the PAP NAP for Increasing Patient Utilization of Positive Airway Pressure Therapy

0578 Feasibility and Preliminary Efficacy of WePAP, a Dyadic Transdiagnostic Intervention

Pilot study of positive airway pressure usage, patient journey and program engagement for users of a digital obstructive sleep apnea program

Positive Airway Pressure Adherence and Health Care Resource Utilization in Patients With Obstructive Sleep Apnea and Heart Failure With Reduced Ejection Fraction

0538 Healthcare Resource Utilization in Treated Obstructive Sleep Apnea Patients with Comorbid Insomnia

Effect of telemonitoring and as-needed patient support on positive airway pressure therapy adherence

Adherence to long-term non-invasive positive airway pressure therapy

0565 Utilization of Pap Titration as Indicator for Prediction of Pap Adherence

0574 An Intervention to Promote Positive Airway Pressure (PAP) Use: Qualitative Analysis of Barriers and Facilitators

Predictors of Positive Airway Pressure Therapy Adherence Among U.S. Active Duty Military Personnel With Obstructive Sleep Apnea

0561 CPAP Tolerance Scores Are Effective in Predicting CPAP Usage in the Short-Term

0585 PAP Therapy Impact on Bariatric Surgery Complications: A 30-Day Pre-Operative Evaluation

Correlation between positive airway pressure and medication adherence: the healthy user effect

Testing a consumer wearables program to promote use of positive airway pressure therapy in patients with obstructive sleep apnea: protocol for a pilot randomized controlled trial

0573 Morning Questionnaire Post-PAP Titration as a Prediction Tool of Early PAP Adherence

Healthcare resource utilisation and costs in patients with treated obstructive sleep apnea

0571 Impact of CPAP Adherence on Objective and Subjective Sleepiness Measures

0566 Utilizing a Triage Tool Questionnaire to Identify PAP-Related Issues in Patients Newly-Initiated on Therapy for OSA

1156 “NIV Nap” to Improve PAP Acceptability and Hypoventilation in Neuromuscular Disease

0596 Comparative Analysis of Continuous Positive Airway Pressure and Hypoglossal Nerve Stimulation

Hypoglossal nerve stimulation versus positive airway pressure therapy for obstructive sleep apnea